1. Andersen, M. E., Mills, J. J., Fox, T. R., Goldsworthy, T. L., Conolly, R. B., and Birnbaum, L. S. (1994). Receptor mediated toxicity and implications for risk assessment. In Receptor-Medicated Biological Processes. Implications for Evaluating Carcinogenesis (H. L. Spitzer, T. J. Slaga, W. F. Greenlee, and M. McClain, Eds.), pp. 295–310. Wiley-Liss, New York.
2. Ariens, E. J., van Rossum, J. M., and Koppman, P. C. (1960). Receptor reserve and threshold phenomena. I. Theory and experiments with autonomic drugs tested on isolated organs. Arch. Int. Pharmacodyn.127,459–478.
3. Aylward, L. L., Brunet, R. C., Starr, T., Delzell, E., Cheng, H., and Beall, C. (2004). Exposure reconstruction for the TCDD-exposed NIOSH cohort using a concentration- and age- dependent model of elimination. Organohalogen Compounds66,3394–3401.
4. Aylward, L. L., Brunet, R. C., Carrier, G., Hays, S. M., Cushing, C. A., Needham, L. L., Patterson, D. G., Gerthoux, P. M., Brambilla, G., and Mocarelli, P. (2005). Concentration-dependent TCDD elimination kinetics in humans: Toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort. J. Expo. Anal. Environ. Epidemiol.15,51–65.
5. Becher, H., Steindorf, K., and Flesch-Janys, D. (1998). Quantitative cancer risk assessment for dioxins using an occupational cohort. Environ. Health Perspect.106(Suppl. 2),663–670.